Alkermes (ALKS) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ALKS Hot Sheet
Price: $45.89 +0.44%
Financial Fact:
INCOME TAX BENEFIT: -880K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
INCOME TAX BENEFIT: -880K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Alkermes (NASDAQ: ALKS) reported Q2 EPS of $0.11, $0.01 better than the analyst estimate of $0.10. Revenue for the quarter came in at $130.2 million versus the consensus estimate of $135.79 million.
For earnings history and earnings-related data on Alkermes (ALKS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alkermes (ALKS) PT Raised to $50 at H.C. Wainwright
- Corpay, Inc. (CPAY) Tops Q3 EPS by 35c; offers guidance
- Clover Health Investments (CLOV) Tops Q3 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
